Swiss stocks are showing modest gains in mid-day trading on Thursday. The move continues the modest uptick the market has seen in the last few days, stabilizing after the sharp drop experienced on Monday.
Volume is light and lingering concerns about the debt situation in Europe are keeping traders on the sidelines. Economic data from the U.S. will help guide trading during the afternoon.
The benchmark SMI is up 0.07 percent to 6,468.83. The SLI is up 0.19 percent to 1,008.95. The SPI is up 0.11 percent to 5,949.17.
Nobel Biocare is one of the most notable gainers on the day. Shares are up 6.8 percent on positive analyst comments. Morgan Stanley raised its rating to Overweight from Underweight, citing substantive improvement in the dental implant market.
UBS is gaining ground as well. There is a report in the Wall Street Journal that the firm plans to separate its investment bank and incorporate it outside of Switzerland. Shares are up 1.5 percent.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.